Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Inhaled apomorphine, at doses up to 0.8 mg, appears safe and well tolerated by patients with Parkinson’s disease, but does not result in significant improvement in wearing “off” periods, at the tested doses.

Inhaled Apomorphine as a Rescue Treatment in Parkinson’s Diseas